Kick-off of the Can Ruti Campus Advanced Therapies Programme
Kick-off of the Can Ruti Campus Advanced Therapies Programme
On 5 November, the Can Ruti Campus held the kick-off meeting for the PATH Advanced Therapies Programme, a research initiative co-led by Dr Joan Vidal, rehabilitation physician and Director of Education at Guttmann, and Carolina Gálvez-Montón, a researcher at the Germans Trias i Pujol Research Institute (IGTP). Led by the IGTP, the project aims to advance the development, validation and clinical translation of treatments based on gene therapy, cell therapy and tissue engineering.
The kick-off brought together research groups, clinicians and companies to share expertise and capabilities and foster collaboration. The event combined presentations on the participating groups’ research with sessions on manufacturing, regulation and clinical application.
Vidal presented PATH’s strategic objectives and moderated the session on regulation, innovation and technology transfer, with a particular focus on clinical development requirements, intellectual property and project support services. Iñigo Pérez, Guttmann’s Clinical Trials Coordinator and a member of PATH’s coordination group, moderated the clinical translation session, which explored experiences in moving from preclinical research to human use, manufacturing for clinical application, and cell therapies for spinal cord injuries and autoimmune diseases.
Strengthening the connection between research and clinical practice
Advanced therapies are a particularly relevant area of research for the future of personalised medicine and the development of new therapeutic strategies. “PATH allows us to strengthen the connection between research and clinical practice and bring a neurorehabilitation perspective to the programme. At Guttmann, we want to help turn advances in this field into new therapeutic opportunities for patients,” says Vidal.
The programme’s main objectives include:
-
Promoting translational research into advanced therapy medicinal products.
-
Developing and consolidating technological platforms and resources to ensure manufacturing and validation meet quality standards.
-
Fostering multidisciplinary collaboration with academic institutions, clinical centres and companies.
-
Promoting specialised training and knowledge sharing in advanced therapies.
PATH operates within the alliance of ten centres that make up the [Germans Trias Health Research Institute (IIS)](https://www.germanstrias.org/ca/about-us/ac